US BANCORP \DE\ - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q1 2021$11,000
-21.4%
3,0000.0%0.00%
Q4 2020$14,000
-72.5%
3,0000.0%0.00%
Q3 2020$51,000
+82.1%
3,000
+20.0%
0.00%
Q2 2020$28,000
+133.3%
2,5000.0%0.00%
Q1 2020$12,000
+1100.0%
2,500
+809.1%
0.00%
Q4 2019$1,0000.0%2750.0%0.00%
Q3 2019$1,0000.0%2750.0%0.00%
Q2 2019$1,0000.0%2750.0%0.00%
Q1 2019$1,0000.0%2750.0%0.00%
Q4 2018$1,0000.0%2750.0%0.00%
Q3 2018$1,0000.0%2750.0%0.00%
Q2 2018$1,0000.0%2750.0%0.00%
Q1 2018$1,0000.0%2750.0%0.00%
Q4 2017$1,0000.0%2750.0%0.00%
Q3 2017$1,0000.0%2750.0%0.00%
Q2 2017$1,0000.0%2750.0%0.00%
Q1 2017$1,0000.0%2750.0%0.00%
Q4 2016$1,0000.0%2750.0%0.00%
Q3 2016$1,0000.0%2750.0%0.00%
Q2 2016$1,0000.0%2750.0%0.00%
Q1 2016$1,0000.0%2750.0%0.00%
Q4 2015$1,0000.0%2750.0%0.00%
Q3 2015$1,0000.0%2750.0%0.00%
Q2 2015$1,0000.0%2750.0%0.00%
Q1 2015$1,0000.0%2750.0%0.00%
Q4 2014$1,0002750.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Weaver Consulting Group 130,000$437,0000.21%
Ikarian Capital, LLC 304,161$1,022,0000.13%
ABNER HERRMAN & BROCK LLC 265,000$890,0000.12%
S.C. Financial Services, Inc. 15,285$51,0000.06%
JMAC ENTERPRISES LLC 45,430$153,0000.04%
CFO4Life Group, LLC 12,000$40,0000.01%
OSAIC HOLDINGS, INC. 10,839$1,329,0000.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 29,186$98,0000.00%
RAYMOND JAMES & ASSOCIATES 190,403$640,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders